ripekg:evaluation/RIPEA3A616563C128D80E |
prov:used |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
rdf:type |
rdfs:Resource |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
rdf:type |
owl:Thing |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
rdf:type |
ripe:RegistryEvidenceRegistry evidence |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
rdf:type |
tido:Evidence |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
prov:wasAttributedTo |
ripekg:source/clinicaltrials-govClinicalTrials.gov |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA3A616563C128D80E |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA3A616563C128D80E |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
ripe:concerns |
ripekg:work/10.1002%2Fptr.6406Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
ripe:isProspective |
false |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
ripe:registrationAssessmentRationale |
Comparison performed at month level. Registration: 2017-12, LLM Recruitment Start: 2017-06. Deemed retrospective at month level. |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
ripe:registrationDate |
13-12-2017 |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
ripe:registrationId |
NCT03377140 |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
ripe:registrationLink |
https://clinicaltrials.gov/study/NCT03377140 |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
ripe:registryName |
ClinicalTrials.gov |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-human-2-2 |
ripekg:registry-evidence/RIPEA3A616563C128D80E |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3A616563C128D80E-inspectai-2-2 |